Isabella Z. | Natural News | Jan. 31, 2018

With all the alarming flu death headlines making the rounds these days, it’s easy to see how someone could be frightened into taking flu medications to be “on the safe side.” Unfortunately, the popular flu drug Tamiflu is anything but safe, and more examples of its potential dangers are coming to light as the flu epidemic continues in full swing. So why exactly is this drug, which has been banned for children in Japan, still so highly recommended in the U.S.?

In the latest Tamiflu nightmare, a two-year-old experienced hallucinations that caused him to become violent after taking the medication. The young boy, who is normally calm, slapped his mother in the face shortly after taking the drug. He twitched all night, and he began to pick invisible items off his arms, saying that they hurt him. His hallucinations, seizures, and odd behavior stopped after his parents took him off of the flu drug.

Earlier this year, a six-year-old girl who was taking Tamiflu tried to jump out of her second-story bedroom window, while an 11-year-old Texas girl told her father she heard the voice of the devil in her head while taking the medication.

The parents of a 16-year-old boy from Indiana believe that Tamiflu caused him to take his own life last week. They report that the boy had never expressed any type of suicidal thoughts in the past, nor did he have any signs of depression. He was thriving in school and sports. The only thing that changed in the days leading up to his suicide, they say, is that he had started taking Tamiflu. They say that they were not warned properly about the side effects, as the drugs warning label mentions “abnormal behavior” without explaining what exactly that could entail. His distraught mother is now trying to spread the word to spare others such a tragedy. Tamiflu, not surprisingly, wouldn’t comment on the specific case, but they did state: “Neuropsychiatric events have been reported during the administration of Tamiflu in patients with influenza, especially in children and adolescents.”

The drug’s informational insert does mention “neuropsychiatric events” but the language is very soft, suggesting they could be caused by the flu itself. In Japan, there have been so many reports of dangerous hallucinations that giving it to children and teens has been prohibited. There, a concerning number of reports came in of young people trying to jump from vehicles and windows and running out in traffic while taking the drugs. Several young people attempted suicide while taking Tamiflu, and a few were successful. 2005 saw 12 deaths and over 100 cases of odd behavior that included hallucinations and delirium in Japan.

Why do doctors continue to give this drug to American children?

Therefore, it’s not surprising that Japanese authorities banned the drug in those aged 10 to 19 back in 2007, and South Korea came out with a similar warning. The only thing that is surprising is that it is still routinely given to American children with flu. With more than 550 confirmed cases of Tamiflu-induced hallucinations on record in the country since 2009, it’s nothing short of outrageous that more isn’t being done about this problem. It’s even more mind-boggling when you consider how many times this could have happened and a connection to Tamiflu either wasn’t made or wasn’t reported.

There is no doubt that the flu can be quite serious, but the drug’s efficacy record doesn’t make it worth the risk. The CDC itself has admitted that people with the flu who are otherwise healthy do not need antiviral drugs. Yet doctors continue to prescribe it to young people across the nation. How many people have to report these scary side effects – or even die – before something is done?


Contributed by Isabelle Z. @ NaturalNews.com

Natural News is a science-based natural health advocacy organization led by activist-turned-scientist Mike Adams, the Health Ranger.


SHARE:

Vicki Batts | Natural News | Jan. 23, 2018

Freedom in Florida is under attack again, as state legislators seek to pass multiple vaccine-related bills to restrict personal liberty. Under these unconstitutional pieces of legislation, law-makers would “delete” parental rights regarding vaccine tracking. Senate Bill 1680 was filed on January 5, 2018 — and under this bill, parents would no longer have the right to “opt-out” of having their child’s vaccination status monitoring by bureaucratic government agencies.  This bill would require students have a vaccination record on file with the government to attend school.

House Bill 1045, introduced December 19, 2017, seeks to exact similar measures — by requiring “electronic availability” of vaccination records. The bill would also revise the vaccine requirements needed for public school students. HB 1045 would also demand that students have a “certificate of immunization on file with the Department of Health.”

Both bills serve to restrict a parent’s right to protect their children’s privacy — or rather, eliminate it entirely.

The Florida State Health Department already operates a vaccine registry, but under current laws, parents still have the right to refuse to participate if they don’t want their children on “the list.” But, as a recent release from the Florida National Vaccine Information Center (NVIC) Advocacy Team explains:

However, the health department has been openly circumventing the current law keeping everyone’s information without legal authority even after someone opts out using the state provided form. Instead of deleting records, the health department admits they will keep them and will only limit data sharing as they admit on their site: “If you choose to opt out, your child’s record will continue to be in the registry, but it will not be accessible to anyone but the child’s current doctor.”

So, even opting out doesn’t delete a child’s record in its entirety; what kind of liberties will the government grant themselves under these new (unconstitutional) bills? Urgent action is needed to oppose these bills and protect health freedom in Florida. As the Florida NVIC team contends, SB 1680 and HB 1045 pave the way to legalize the government’s atrocious (and presently illegal) actions regarding those who try to opt-out. Further, these two bills will remove parental choice in virtually every sense.

You can learn more about contacting your Florida state representatives to oppose these bills here.

Another controversial bill was also introduced in Florida — one that would mandate all public school students be vaccinated with the highly detested HPV vaccine. Despite the numerous reports of harm, Florida politicians are seemingly doing everything in their power to appease Big Pharma. In addition to trying to force every parent and child to take part in their Big Brother-ish vaccine registry, they are also trying to coerce parents into vaccinating their children with an inoculation that has harmed countless children.

Under Florida’s  SB 1558, male and female students between 11 and 12 years old would be forced to get the HPV vaccine — if they wish to continue attending school. Some are even calling SB 1558 the “Women’s Cancer Prevention Act,” despite the fact that it is egregiously incorrect to claim that any vaccine will flat-out prevent cancer. Even the former Merck scientist who helped create these worthless jabs has admitted “there is no actual evidence that the vaccine can prevent any cancer.”

So, why must children be forced to get the HPV vaccine? Further, you might question what right does the government have to enforce these kinds of absurd laws that completely violate your rights as a parent — and your child’s rights as a human being.

As usual, establishment politicians seem to have little concern for the actual well-being of their constituents. It is up to the people of Florida to speak up and demand that their government officials stop trying to trample over personal liberty. [Related: Read more stories like this at HealthFreedom.news.]


Originally Published @ Natural News


SHARE:


Jhoanna Robinson | Natural News | Nov. 29, 2017

The National Health Service is eyeing the cessation of the incessant prescription of Liothyronine, a drug that is used to treat thyroid disorders, after its manufacturer, Oakville, Canada-based pharmaceutical company Concordia International, increased its retail price by 5,662 percent to 9.22 British pounds from 16 p per tablet.

Liothyronine is used to treat hypothyroidism or underactive thyroid, which affects 15 in every 1,000 women and one in every 1,000 men in the United Kingdom. Hypothyroidism is characterized by a poor ability to tolerate cold, constipation, a feeling of tiredness, depression, and weight gain.

An underactive thyroid means your thyroid doesn’t produce enough hormone, and can be caused by many things, including lifestyle. In more severe cases, it can occur when the immune system attacks the thyroid gland and damages it, or when the thyroid sustains damage that was caused by treatments for an overactive thyroid or thyroid cancer.

As there is only one supplier of Liothyronine, patients could be forced to go all the way to Europe, where a packet costs only around a few euros.

According to TheTimes.co.uk, Liothyronine, which is a synthetic version of the hormone triiodothyronine or T3 (hormone produced by the thyroid gland), is “clinically effective but…has been subject to excessive price inflation,” noting that some health trusts have already stopped funding it.

NHS reported that it prescribed liothyronine to around 13,000 patients in 2016. Prescriptions of the medicine by the NHS reached costs that were around 30.6 million British Pounds in 2016, up from 3.7 million British Pounds in 2011.

Thyroid U.K. chief executive Lyn Mynott said she had been besieged with phone calls from panicking thyroid patients. “I think it’s going to be devastating for some. They are afraid they are going to be stopped and are expecting to become ill again.”

A spokeswoman for Concordia International said the price hike was necessary as the medicine was “incredibly difficult to manufacture.” (Related: The dirty history of Big Pharma’s scientific censorship, oppression and destruction of human knowledge.)

Higher levels of thyroid hormone associated with increased risk of heart disease

A recent study showed that older adults with a higher level of free thyroxin (FT4, which is a hormone that is produced by the thyroid gland) have incredibly high chances of developing coronary artery calcification scores, which is a key indicator of atherosclerosis.

“We expected that thyroid function would influence the risk of developing atherosclerosis by affecting cardiovascular risk factors such as blood pressure. However, our results remained very similar after accounting for several cardiovascular risk factors,” said lead author Arjola Bano, from the University of Erasmus in the Netherlands.

“Our findings suggest that thyroid hormone FT4 measurement can help identify individuals at increased risk of atherosclerosis,” Bano added.

For more stories on the activities of big pharmaceutical companies, whether they are unscrupulous or not, visit BigPharmaNews.com today.


SOURCE: Natural News


SHARE:


Jake Anderson | AntiMedia | Nov. 27, 2017

It’s been a controversial month for the FDA. They drew the ire of kratom community by seeking to ban imports of the popular, safe pain reliever. During that same week, the agency approved the use of pills with sensors for the first time. The drugs, dubbed “smart pills,” are the first medication to be approved with a “digital ingestion tracking system.” While the ostensible purpose of “smart pills” is improved compliance and enhanced medical data, some critics are viewing the move as an Orwellian overture.

The “digital ingestion tracking system” will first be integrated into the atypical antipsychotic drug Abilify MyCite; it will record whether the drug was actually ingested.

In a press release, the FDA announced:

“The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.”

The pill’s internal sensor contains copper, magnesium, and silicon. Upon exposure to stomach acid, it generates an electrical signal that is transmitted to a “wearable patch.” The information is forwarded from the patch to a smartphone app or physicians and caregivers associated with the patient.

In another press release, Mitchell Mathis, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research, said that “[b]eing able to track ingestion of medications prescribed for mental illness may be useful for some patients.”

Others are not so optimistic. “There’s an irony in it being given to people with mental disorders than can include delusions. It’s like a biomedical Big Brother,”  said Dr. Jeffrey Lieberman, chairman of psychiatry at Columbia University and New York-Presbyterian Hospital.

In a statement to the Anti-Media, Jamie Williams, Press Director for the Electronic Frontier Foundation (EFF), raised concerns over privacy and patient understanding:

“There’s certainly privacy issues with these devices, just like with any devices that collect and transmit data about us, especially when the data is highly sensitive medical information. Information about exactly when you took exactly how much of a drug is not information thatcurrently exists right now. Its highly invasive and personal information about what is happening inside your body, which is what I think is drawing the ‘bio-medical Big Brother’ analogy. Instead of being able to read what’s going on inside your brain/thoughts, it can read what’s going on inside your stomach.

“Anyone who volunteers to swallow one of these pills needs to understand what that means, in terms of what data is collected, how it’s being used, and where it’s being stored? Are there situations in which law enforcement may want to access data about how much of a drug you had in your system at any given time, and what are the restrictions on their access?”

Some have noted the benefits of reining in medical costs, as experts say the healthcare industry spends $100 billion a year on ‘nonadherence or noncompliance.’

“This data is supposedly being collected to help patients and save the system money, but what are the limitations on making sure it’s not used to surveil everything they are putting into their stomach?” Williams asks. “The potential for surveillance and data mining will all depend on the limitations on collection, use, and storage of this data. New technologies are usually misused and abused first against the most powerless groups.”

We likely haven’t heard the end of the issue, and this is probably just the opening salvo of a “smart drugs” debate that could rage on for decades. As anxiety about government and corporate surveillance grows, will a line be drawn or will the public continue to acquiesce to invasive technology?


Originally Published @ Anti-Media


SHARE:

President Trump has nominated a former lobbyist and executive of a major pharmaceutical company to be U.S. Health Secretary. 

Derrick Broze | Activist Post | Nov. 15, 2017

On Monday, Trump announced his pick for Secretary of the Department of Health and Human Services. “Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices,” Trump tweeted. The nominee immediately came under scrutiny for his former connections to the pharmaceutical industry.

Azar formerly served as U.S. Deputy Secretary of Health and Human Services under George W. Bush from 2005 to 2007. In June 2007, Azar began working as a lobbyist for pharmaceutical giant Eli Lilly and Company. Azar also served as Eli Lilly’s spokesman as its Senior Vice President of Corporate Affairs and Communications. Beginning January 1, 2012, Azar was promoted to President of Lilly USA, LLC, the largest division of Eli Lilly and Company – a position which put him in charge of Eli Lilly’s entire U.S. operation.

During his tenure at Eli Lilly, prices for drugs were repeatedly raised, including doubling the top-selling insulin. Eli Lilly has also previously come under investigation for “systematic and illegal off-label sales” of a powerful psychiatric drug called Zyprexa. As the result of an investigation into Eli Lilly’s activities between 1999 and 2005, the company plead guilty and agreed to a $1.415 billion fine for promoting uses of the drug which were not approved by the Food and Drug Administration (FDA). Although Alex Azar was not yet in charge of the company during this investigation it is indicative of the type of actions Eli Lilly has taken.

Reuters reported that Democratic Representative Elijah Cummings said the nomination of Alex Azar to Health Secretary was “like a fox guarding the hen house.” The nominee must be approved by the U.S. Senate before it becomes official.

If Alex Azar is approved as the head of the Department of Health and Human Services he would be responsible for oversight of the U.S. FDA, the agency responsible for regulating the drug industry. Azar will be joined by Scott Gottlieb, Trump’s equally controversial appointment to Commissioner of the FDA. During Gottlieb’s confirmation hearings, Senator Ed Markey called attention to Gottlieb’s close ties to pharmaceutical companies that sell and promote opioids. “We need FDA to be a tough cop on the beat, not a rubber stamp approving the latest big pharma painkillers,” Markey said at the time.  With Alex Azar and Scott Gottlieb in control of the FDA regulatory process it is likely the U.S. can expect an increase in support for opioids.

Interestingly, until recently Alex Azar was also a member of the board of directors of the Biotechnology Innovation Organization, a pharmaceutical lobby. As the organization’s name implies, they support the advancement of biotechnology, including the use of genetically engineered or modified organisms in food. A statement on BIO’s site repeats the myth that “plants and animals derived from biotechnology, so-called GMOs, are needed to help feed the world safe, healthful and affordable food in a more environmentally sound and sustainable way.”

supported the federal GMO “labeling” bill which opponents referred to as the Deny Americans the Right to Know, or DARK Act, because the bill actually prevents local governments and states from being able to set their own labeling laws. Instead, the bill puts the federal government in charge of the process. The signing of the bill caused concern among proponents of transparency and safety due to the U.S. governments revolving door with executives from Big Pharma and Biotech companies such as Monsanto.

One final note on Alex Azar’s history which may be interesting to our readers is the fact that on August 3, 2001, Azar was confirmed to be the General Counsel of the U.S. Department of Health and Human Services. Azar is reported to have played an important role in responding to the 2001 anthrax attacks which have been proven to be a false flag. Azar is said to have been involved preparing a vaccine in response to these false flags.

The Swamp Is Not Being Drained

If you have been paying attention (or reading Activist Post) you would have seen this coming. In late January, Trump held a private meeting in the Oval Office with Big Pharma execs. At the beginning of the meeting Trump was quoted “We have to get prices down. We have no choice.” After the meeting Trump seemed to be singing a different tune. In February Newsweek reported:

Trump said he will be “streamlining the process” so that companies do not have to wait years for a new product to be approved. Although he did not provide details, he hinted that his yet-to-be-named chief of the Food and Drug Administration has some plans. (This would turn out to be the Big Pharma friend Scott Gottlieb)

The president has repeatedly vowed to curtail government regulation in general, most recently with an executive order requiring the removal of two regulations for every new one introduced. And although granting Medicare the ability to negotiate drug prices was one of the president’s major campaign promises, he has abandoned it. Without the power to limit pricing or more restrictive patent laws it is unclear how the federal government could have any impact on drug costs.

The Executive Orders mentioned were touted as removing harmful regulations from hard working Americans, but in reality these EOs further entrenched the power of Big Pharma. Business Insider wrote that “Trump just sold us all out on drug pricing,” while The Hill wrote:

Another policy that is under discussion would instruct agencies to pursue trade policies that would strengthen the intellectual property rights of pharmaceutical companies.

Such industry-friendly policies would be a dramatic departure from what President Trump promised on the campaign trail.

In conclusion, Trump’s appointment to Secretary of the Department of Health and Human Services is the same as his appointment to the head of the FDA – he is an establishment insider who is closely connected to (and formerly employed by) a major pharmaceutical company. His close ties to this industry – as well as opioid makers – does not fare well for the future of America’s opiate crisis or the general health of all Americans. We should expect to see the reliance on pharmaceuticals increase as these corporations become further enmeshed with the U.S. government.


Derrick Broze is an investigative journalist and liberty activist. He is the Lead Investigative Reporter for ActivistPost.com and the founder of the TheConsciousResistance.com. Follow him on Twitter. Derrick is the author of three books: The Conscious Resistance: Reflections on Anarchy and Spirituality and Finding Freedom in an Age of Confusion, Vol. 1 and Finding Freedom in an Age of Confusion, Vol. 2


SHARE: